首页> 外文期刊>Pathology International >CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma of ocular adnexal origin: Usefulness of fluorescence in situ hybridization for distinction between mantle cell lymphoma and MALT lymphoma.
【24h】

CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma of ocular adnexal origin: Usefulness of fluorescence in situ hybridization for distinction between mantle cell lymphoma and MALT lymphoma.

机译:眼附件的CD5阳性黏膜相关淋巴样组织(MALT)淋巴瘤:荧光原位杂交在区分套细胞淋巴瘤和MALT淋巴瘤方面的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type (MALT lymphoma) usually lacks CD5 expression. Herein is described two cases of CD5-positive MALT lymphoma of ocular adnexal origin. The differential diagnosis between CD5-positive MALT lymphoma and mantle cell lymphoma (MCL), notably cyclin D1-negative MCL, was difficult because both cases consisted histologically of small to medium-sized cells with diffuse or vaguely nodular growth pattern, and the neoplastic cells were positive for CD5 and negative for cyclin D1. Somatic mutation analysis of the immunoglobulin heavy chain variable region (VH) gene in case 1 found a relatively higher mutation frequency (5.0%), which was not definitive to rule out MCL. Interphase fluorescence in situ hybridization (FISH) on paraffin-embedded section using IgH/cyclin D1 (CCND1) probe showed that in both cases there was no molecular evidence of t(11;14), finally leading to the diagnosis of CD5-positive MALT lymphoma. Although the present two patients had no recurrence over 34 months after initial diagnosis, careful observation is needed because the clinicopathological significance of MALT lymphoma with this rare phenotype remains obscure.
机译:粘膜相关淋巴样组织类型的结外边缘区B细胞淋巴瘤(MALT淋巴瘤)通常缺乏CD5表达。本文描述了两例眼附件起源的CD5阳性MALT淋巴瘤。 CD5阳性MALT淋巴瘤和套细胞淋巴瘤(MCL)尤其是细胞周期蛋白D1阴性MCL很难进行鉴别诊断,因为这两种病例在组织学上均由具有弥散或模糊结节性生长模式的中小型细胞和肿瘤细胞组成CD5阳性,而cyclin D1阴性。案例1中的免疫球蛋白重链可变区(VH)基因的体细胞突变分析发现相对较高的突变频率(5.0%),尚不能排除MCL。使用IgH / cyclin D1(CCND1)探针在石蜡包埋的切片上进行相间荧光原位杂交(FISH)显示,在两种情况下均没有t(11; 14)的分子证据,最终导致CD5阳性MALT的诊断淋巴瘤。尽管目前两名患者在最初诊断后的34个月内未复发,但仍需仔细观察,因为具有这种罕见表型的MALT淋巴瘤的临床病理意义仍然不清楚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号